Epiligrin, the major component of human keratinocyte extracellular matrix, serves as the preferred integrin ligand for a3ft in plasma membranes and focal adhesions, and colocalizes with a684 in hemidesmosomes. In human skin, epiligrin is found in the lamina lucida subregion of epidermal basement membrane, where it is thought to be associated with anchoring filaments. We have identified three patients with an acquired mucosal predominant subepidermal blistering disease who have IgG anti-basement membrane autoantibodies that bind the lamina lucida/lamina densa interface of epidermal basement membrane, stain cultured human keratinocyte extracellular matrix, and immunoprecipitate disulfide linked polypeptides of 170, 145, 125, and 95 kD in human keratinocyte culture media in a pattern identical to that of PlEl, a murine monoclonal antiepiligrin antibody. Comparative immunoprecipitation studies of patient sera, PlEl, and GB3 monoclonal antibody show that epiligrin is identical to the antigen (i.e., BM600 or GB3 antigen) previously reported to be absent from the skin of patients with lethal junctional epidermolysis bullosa, an inherited subepidermal blistering disease. Moreover, skin from a fetus with this disease shows no evidence of reactivity to patient antiepiligrin autoantibodies or PlEl. These studies show that antiepiligrin autoantibodies are a specific marker for a novel autoimmune blistering disease and that the epidermal basement membrane antigen absent in patients with lethal junctional epidermolysis bullosa is epiligrin. (J. Clin. Invest. 1992. 
Introduction
The stratified squamous epithelium of human epidermis is derived from a proliferating basal keratinocyte cell layer that is attached to the underlying epidermal basement membrane (BM).' Adhesion of basal keratinocytes to epidermal BM is critical for maintenance ofepithelial cell polarization, differentiation, morphogenesis, and wound healing. Basal keratinocyte adhesion to epidermal BM is mediated by integrin receptors a3f31 in plasma membranes and focal adhesions, as well as a634 receptors in hemidesmosomes ( 1, 2) . While these integrin receptors have traditionally been thought to bind laminins in epidermal BM, the latter are poor ligands for adhesion of cultured human keratinocytes in vitro. Recently, Carter et al. have characterized a human keratinocyte extracellular matrix (ECM) glycoprotein complex termed epiligrin that is the major component of keratinocyte ECM and that serves as the preferred ligand for a3#1 in plasma membranes and focal adhesions, and colocalizes with a634 in hemidesmosomes (2) . In human skin, epiligrin is found in the lamina lucida subregion of epidermal BM adjacent to a3#1 and a34 in basal keratinocytes. As the major keratinocyte integrin ligand, epiligrin is thought to play a key role in the attachment of the epidermis to BM.
We have identified three patients with an acquired autoimmune blistering disease characterized by separation of the epidermis from BM who have IgG anti-BM autoantibodies that bind human skin, cultured human keratinocyte ECM, and epiligrin in human keratinocyte culture media in a pattern identical to that of PlE1, a murine monoclonal antiepiligrin antibody. Furthermore Immunoperoxidase studies. Cryostat sections (6 ,m) ofskin from a human fetus with LJEB and skin from a normal human fetus were reacted with serum from a representative patient, normal human serum (negative control), P1 E murine monoclonal antiepiligrin antibody, or monoclonal antitenascin antibody (positive control), washed, and then developed with the appropriate peroxidase-conjugated second-step antibodies, as previously described (2). Immunoelectron microscopy. Direct and indirect IgG immunoelectron microscopy was performed as previously described (1O, 11). In brief, a multistep immunoenzyme technique was used to characterize in situ immunoreactants in patient skin samples, as well as IgG antiepidermal BM reactivity ofpatients' sera, normal human serum (negative control), PIE1, and murine monoclonal anti-human IgG, antibody (negative control). Biosynthetic radiolabeling of human keratinocyte culture media. Subconfluent monolayers of human keratinocytes (to avoid confluence-associated differentiation changes that occur in epithelial cell cultures) in methionine-free media ( KGM; Clonetics Corp.) were metabolically labeled with [35S]methionine (50 MCi/ml; specific activity -1100 Ci/mmol, New England Nuclear, Boston, MA) for 24 h (7, 12) . Recovered culture media was made 1 mM in EDTA and PMSF, centrifuged at 750 g for 1O min, recovered, dialyzed extensively against 0.01 M Tris-HCl, 0.15 M NaCl, pH 7.4 (Tris-buffered saline [ TBS]) at 4°C, and then stored at -70°C.
Immunoprecipitation. The protein content of radiolabeled human keratinocyte culture media aliquots was estimated by trichloroacetic acid precipitation and used to determine equal sample inputs for immunoprecipitation experiments. Immunoprecipitation experiments were performed as previously described (7, 12, 13) . In brief, aliquots of radiolabeled media were preabsorbed with normal human serum (or normal mouse and rabbit serum in two-step immunoprecipitation studies using murine monoclonal antibodies and rabbit anti-mouse IgG), twice mixed with freshly washed Pansorbin, then incubated overnight at 4VC with 10 Al of serum (patient or control subjects) or murine monoclonal antibodies. Freshly washed Pansorbin (200 Ml of a 10% wt/vol suspension) was added to each sample for 1 h at 4VC. Pansorbin aliquots were then washed three times with TBS containing 0.3% Triton X-100, 0.3% sodium deoxycholate, 0.3 mM NaCl, 0.1% BSA, three times with the same buffer without BSA, and once with half ionic strength buffer without BSA. Pansorbin, immunoglobulin, and antigens were dissociated in 100 Ml of 2% SDS±0. 1 M DTT at 100IC for 2 min. Immunoprecipitation samples were recovered and studied by SDS-PAGE and fluorography. The molecular weights of bands in fluorographs was calculated relative to the migration of '4C-labeled protein standards.
Affinity purification studies. To show that IgG anti-BM autoantibodies in patient serum were specifically reactive with polypeptides in human keratinocyte culture media, aliquots of patient (two subjects) or control sera were affinity purified on lamina densa/dermal components of 1 M NaCl split human skin ( 14). In brief, strips of lamina densa/dermis were separately incubated with patient or control sera ( 1:5 in PBS) for 90 min at room temperature and then washed extensively with PBS. Anti-BM antibodies were eluted with 20 mM sodium citrate, pH 3.2, neutralized immediately with 2 M Tris, pH 9.0, dialyzed extensively against TBS for 16 h at 4°C, and concentrated by ultrafiltration (Centricon 30; Amicon Corp., Danvers, MA). Affinitypurified anti-BM antibodies were analyzed in indirect immunofluorescence microscopy studies of 1 M NaCl split skin, as well as immunoprecipitation studies of radiolabeled human keratinocyte culture media.
Results and Discussion
All of our patients with blistering, erosive, and scarring lesions of mucous membranes have circulating IgG anti-BM autoantibodies that exclusively bind the dermal (rather than the epidermal) side of 1 M NaCl split skin (titers: 1:160, 1:5, and 1:40) (Fig. 1 A) . By immunoelectron microscopy, these patients show in situ deposits of immunoreactants and circulating IgG autoantibodies that bind the lamina lucida/lamina densa interface of epidermal BM (Fig. 1 C) . Moreover, autoantibodies in these patients' sera immunoprecipitate a distinct set ofpolypeptides from culture media of biosynthetically radiolabeled human keratinocytes. Analysis of reduced immunoprecipitation samples shows that patient sera identify polypeptides of 170, 145, 125, and 95 kD (Fig. 2 A, lanes 1-3) . Under nonreducing conditions, these polypeptides remain disulfide linked, migrating as a single, large protein species (2 600 kD; data not shown). To determine whether antiepidermal BM autoantibodies in patient sera (rather than some other circulating Ig species) are responsible for immunoprecipitating these polypeptides, serum samples from two patients were affinity purified on lamina densa/dermal components of epidermal BM in 1 M NaCl split skin, and then characterized in immunofluorescence and immunoprecipitation studies. Affinity-purified anti-BM autoantibodies from these patients exclusively bind the dermal side of 1 M NaCl split skin and immunoprecipitate the same distinct set of polypeptides in keratinocyte culture media described above (Fig. 2 B, lanes 2 and 3) .
The keratinocyte polypeptides identified by these patients' circulating autoantibodies have size characteristics, disulfide linkages, and a distribution within cutaneous BMs such as those of two previously described epidermal BM lamina lucida constituents: epiligrin, the major keratinocyte integrin ligand (2); and BM600, a large keratinocyte-derived glycoprotein an-D . . .. A Figure 1 . IgG autoantibodies in patient serum and PlE I monoclonal antiepiligrin antibody bind only the dermal side of 1 M NaCl split skin in indirect immunofluorescence microscopy studies (A and B, respectively), and specifically localize to the lamina lucida/lamina densa interface of this test substrate by indirect immunoelectron microscopy (C and D, respectively). Normal human serum and control monoclonal antibody show no evidence of reactivity to 1 M NaCl split skin in these studies (data not shown). Patient serum (E) and PlEl (F) (but not controls) show the same pattern of reactivity to the ECM and periphery of cultured A-43 1 cells by indirect immunofluorescence microscopy. Cultured human keratinocytes bind IgG autoantibodies in patient serum and PlE I in the same manner as A-43 1 cells (data not shown).
tigen identified by murine monoclonal antibody GB3 (5) . Interestingly, although the biological role of BM600 has never been defined, previous studies have shown that this antigen is absent in fetal skin samples from patients with LJEB (6), an inherited blistering disease characterized by a defect within the lamina lucida that results in separation ofepidermis from BM. Because epiligrin and BM600 are thought to promote adherence of keratinocytes to ECM in vitro and BM in vivo, it is logical to consider their altered expression in diseases characterized by separation of epidermis from BM. To assess the identity or relatedness ofepiligrin, BM600, and antigens recognized by our patients' circulating autoantibodies, comparative immunoprecipitation experiments were performed (Fig. 2 C) . These studies show that patient sera (Fig. 2 C, lane 2) , PlEl (Fig. 2 C, lane 3) , and GB3 (Fig. 2 C, lane 4) all recognize the same set of polypeptides in keratinocyte culture media. Moreover, preabsorption of keratinocyte culture media with patient serum (but not control normal human serum) removes all polypeptides reactive with patient autoantibodies, PlEl, or GB3 (Fig. 3, lanes 1-3; control studies, Fig. 3, lanes 4-6) . These immunoprecipitation studies show that epiligrin is physically associated with the antigenic target of patient autoantibodies.
Whether the autoimmune epitopes reside on epiligrin itself is yet to be determined. Patient sera and PlEl also demonstrate (a) continuous staining of epidermal BM in normal human skin by indirect immunofluorescence microscopy ( Fig. 1, A  and B) ; (b) staining of the lamina lucida/lamina densa interface ofepidermal BM by indirect immunoelectron microscopy ( Fig. 1, C and D) ; (c) staining ofthe ECM and cell periphery of cultured human keratinocytes and A-43 1 cells, a human epidermoid carcinoma cell line (Fig. 1, E and F) ; and (d) complete absence of reactivity to a prenatal skin sample from a patient with LJEB (Fig. 4, A and B) . That epiligrin is targeted by autoantibodies in an acquired subepidermal blistering disease and absent from the skin ofpatients with a lethal inherited subepidermal blistering disease unify an important number of experimental and clinical observations and provide pathologic correlates that substantiate the key physiologic role(s) of epiligrin in basal keratinocyte adhesion to epidermal BM.
Our findings may also have direct relevance to kalinin, a keratinocyte-derived glycoprotein recently described by Rous- shown in Fig. 2.) ally, both of these proteins are thought to reside in anchoring filaments, elements that link basal keratinocytes to lamina densa and dermal anchoring fibrils. The molecular weights of these polypeptides, their disulfide association, and their ultrastructural localization in skin suggest that kalinin and epiligrin may be the same or related glycoproteins. Moreover, studies in our laboratories have found that autoantibodies from our patients and monoclonal antiepiligrin antibody PlE1 bind human epidermal BM, but they do not react with vascular or renal BMs. These findings demonstrate that epiligrin has the same tissue distribution as previously documented for kalinin and further support the notion that these glycoproteins are identical or closely related. Interestingly, Rousselle et al. reported that skin fragments exposed to antikalinin antibodies extensively de-epithelize as a consequence of cleavage within the lamina lucida ( 15 ). While the mechanism of this detachment is unknown, it suggests that antibodies directed against key adhesive proteins in skin may directly cause separation of epidermis from BM, a finding of potential relevance to the pathogenesis of blisters seen in our patients with antiepiligrin autoantibodies.
Antiepiligrin autoantibodies serve as a specific marker for patients with this blistering skin disorder. We have not identified antiepiligrin autoantibodies in immunoprecipitation studies using serum from other patients with the cicatricial pemphigoid phenotype (n = 5), numerous other patients with subepidermal blistering skin diseases (bullous pemphigoid, n = 16; epidermolysis bullosa acquisita, n = 1; linear IgA dermatosis, n = 1; other subepidermal bullous disease patients, n = 10) (9, 12), one skin disease control patient, or five normal volunteers. These findings suggest the existence of a distinct noso- 
